CBT-I vs MBCT
A side-by-side comparison of recorded mechanisms, evidence review status, related condition topics, and philosophical roots.
At a glance
Source checks, condition-specific assessments and expert review are separate steps. Each assessment applies only to its stated population and use. Topic links do not establish comparative effectiveness.
CBT-I
- Tradition
- Cognitive-Behavioral
- Founder
- Bootzin / Spielman / Morin / Perlis (1987)
- Review status
- 1 condition assessment available
- Official sources
Guidelines and official sources (5)
5 clinical guideline checks
Read the recommendation and its scope. A source may discuss an approach without recommending it.
- Behavioral and psychological treatments for chronic insomnia disorder in adults
Recommendation for the stated population
AASM strongly recommends multicomponent CBT-I. Its 2021 review did not directly compare psychotherapy with medication.
Scope: Adults with chronic insomnia disorder, with or without comorbidities
- Combination treatment for chronic insomnia disorder in adults
Recommendation for the stated population
AASM conditionally favors CBT-I plus medication over medication alone, and CBT-I alone over the combination; both use low-certainty evidence and allow preference-based exceptions.
Scope: Adults with chronic insomnia; concurrent initiation of medication and CBT-I
- Management of chronic insomnia disorder in adults
Recommendation for the stated population
ACP recommends CBT-I initially; after an unsuccessful course, it suggests shared decisions about adding short-term medication.
Scope: Adults with chronic insomnia disorder
- Daridorexant for treating long-term insomnia (TA922)
Discussed in the source
NICE describes CBT-I as the standard first treatment; daridorexant eligibility requires CBT-I to have failed, be unavailable or be unsuitable. This is a drug technology appraisal, so identify that context.
Scope: Adults with long-term insomnia being considered for daridorexant
- Management of Chronic Insomnia Disorder and Obstructive Sleep Apnea
Recommendation for the stated population
VA/DoD strongly recommends CBT-I and weakly favors CBT-I over medication initially. These recommendations address insomnia, not treatment of its comorbid diagnoses.
Scope: Adults with chronic insomnia disorder; initial treatment selection.
- Behavioral and psychological treatments for chronic insomnia disorder in adults
- Focus
- Skill-building
- Format
- Individual or group
- Duration
- Short-term (4–8 sessions)
Condition-specific assessments
Each conclusion applies to the population and use described. These source-based assessments do not certify the full entry or replace expert clinical review.
Insomnia & Sleep Disorders
Population and scope: Adults with chronic insomnia disorder receiving multicomponent CBT-I. This assessment concerns insomnia, including when it co-occurs with another condition; it does not grade treatment of obstructive sleep apnea, circadian disorders or the co-occurring diagnosis itself.
Guideline recommendation
AASM’s 2021 recommendation 1 and VA/DoD’s 2025 recommendation 5 strongly recommend multicomponent CBT-I for adult chronic insomnia. VA/DoD recommendation 8 only weakly favors CBT-I over medication as initial treatment. AASM’s 2026 combination guideline conditionally favors CBT-I alone over starting CBT-I and medication together, with low-certainty evidence and preference-based exceptions. The guideline label therefore applies to the defined insomnia treatment, not sleep hygiene alone, every digital program, every sleep disorder or universal superiority to medication.
Source assessment dated
- American Academy of Sleep Medicine (2021-02-01; JCSM 17(2):255–262; DOI 10.5664/jcsm.8986): Behavioral and psychological treatments for chronic insomnia disorder in adults — Methods and Table 1, printed p. 256 / physical PDF p. 2; Recommendation 1 and Remarks, printed p. 257 / physical PDF p. 3
- US Department of Veterans Affairs / Department of Defense (Version 3.0; January 2025; evidence through 2024-03-31; current PDF filename dated 2025-09-15): Management of Chronic Insomnia Disorder and Obstructive Sleep Apnea — Table 4, recommendations 5 and 8, printed/PDF p. 34
- American Academy of Sleep Medicine (2026-04-13; JCSM 22:56; evidence through June 2025): Combination treatment for chronic insomnia disorder in adults — Recommendations 1 and 2 and remark to Recommendation 2, physical PDF p. 1; Methods/Introduction, physical PDF pp. 1–2; current AASM Practice Guidelines directory
MBCT
- Tradition
- Cognitive-Behavioral
- Founder
- Segal / Williams / Teasdale (2002)
- Review status
- 1 condition assessment available
- Official sources
Guidelines and official sources (14)
13 clinical guideline checks · 1 evidence registry check
Read the recommendation and its scope. A source may discuss an approach without recommending it.
- Depression in adults: treatment and management (NG222)
Recommendation for the stated population
NICE lists group MBCT as a relapse-prevention option, with or without continuing antidepressants according to preference.
Scope: People remitted on antidepressants alone and at higher relapse risk
- Mindfulness-based cognitive therapy
Discussed in the source
The archive lists Strong under 1998 criteria and pending 2015 re-evaluation.
Scope: MBCT; depression/relapse prevention evidence
- Depression in adults: treatment and management (NG222)
Recommendation for the stated population
NICE includes group mindfulness and meditation using a programme such as MBCT among treatment options. This is separate from its relapse-prevention recommendations.
Scope: Adults with a new episode of less severe depression; depression-specific group programme.
- Clinical Practice Guideline for Management of PTSD and Acute Stress Disorder
Insufficient evidence for or against
VA/DoD finds insufficient evidence for or against MBCT for PTSD.
Scope: Adults with PTSD; mind-body interventions.
- Management of Major Depressive Disorder
Recommendation for the stated population
VA/DoD suggests mindfulness-based cognitive therapy among seven unranked psychotherapy options (weak for). Treatment strategy also depends on severity, chronicity, prior response and preference.
Scope: Adults with uncomplicated MDD choosing psychotherapy.
- Management of Major Depressive Disorder
Discussed in the source
VA/DoD strongly recommends first-line evidence-based psychotherapy, referring to the list that includes mindfulness-based cognitive therapy. This is a class-level recommendation, with no preferred individual approach.
Scope: Pregnant or breastfeeding adults with mild-to-moderate MDD.
- Management of Major Depressive Disorder
Recommendation for the stated population
VA/DoD suggests MBCT during continuation treatment to reduce relapse or recurrence (weak for). CBT, IPT and MBCT are not ranked against one another.
Scope: Remitted MDD with high risk of relapse or recurrence.
- Clinical Practice Guideline for the Management of Chronic Multisymptom Illness
Discussed in the source
The guideline discusses an IBS adaptation of MBCT within a weak recommendation for mindfulness-based therapies. This is not a separate recommendation for standard MBCT across all chronic multisymptom illnesses.
Scope: MBCT adapted for IBS within the chronic multisymptom illness guideline.
- Management of Headache
Discussed in the source
The recommendation is neutral for the mindfulness-based therapy category; the discussion includes MBCT. It does not assign MBCT a separate recommendation grade.
Scope: Mindfulness-based interventions for headache treatment or prevention.
- Tinnitus
Discussed in the source
The guideline is neutral for mindfulness-based therapies. MBCT appears in the evidence discussion, without a separate MBCT recommendation grade.
Scope: Mindfulness-based therapies for adults with bothersome tinnitus.
- Management of Type 2 Diabetes Mellitus
Discussed in the source
The review includes MBCT within mindfulness/acceptance interventions. The graded recommendation concerns a stress-reduction programme category, without a separate MBCT grade or established long-term benefit.
Scope: Adults with stress related to type 2 diabetes.
- Clinical Practice Guideline for Management of Stroke Rehabilitation
Discussed in the source
VA/DoD weakly recommends mindfulness-based therapies and specifically reviews MBSR and MBCT. The recommendation is for the therapy family in this post-stroke population.
Scope: Depression following stroke.
- Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts
Discussed in the source
APA includes MBCT among broadly comparable models; it cannot recommend a superior monotherapy.
Scope: Adults with depressive disorders, excluding psychotic depression; initial monotherapy selection.
- Clinical Practice Guideline for Tobacco Use Treatment
Discussed in the source
VA/DoD weakly recommends against standalone mindfulness for this cessation goal. This is category-level guidance; MBCT is not separately graded, and the statement does not address adjunctive use or other conditions.
Scope: Mindfulness used as a standalone treatment for abstinence from tobacco or nicotine.
- Depression in adults: treatment and management (NG222)
- Focus
- Skill + Experiential
- Format
- Group
- Duration
- Short (8-week)
Condition-specific assessments
Each conclusion applies to the population and use described. These source-based assessments do not certify the full entry or replace expert clinical review.
Depression & Mood Disorders
Population and scope: Adults with uncomplicated MDD, or remitted MDD with high relapse risk.
Guideline recommendation
VA/DoD 2022 weakly includes MBCT for initial psychotherapy selection (recommendation 7) and separately for continuation after remission in patients at high relapse risk (22). Neither recommendation establishes superiority; acute treatment and relapse prevention are distinct scopes.
Source assessment dated
How they work
CBT-I
Core mechanism: Sleep restriction and stimulus control consolidate sleep drive and decondition wakefulness; cognitive restructuring reduces hyperarousal and catastrophic thinking about sleep
Ontology: Chronic insomnia as a learned disorder of hyperarousal and conditioned sleeplessness maintained by maladaptive behaviors and beliefs, not a primary neurological deficit
MBCT
Core mechanism: Mindful awareness of depressive cognitive patterns enables decentering and prevents ruminative relapse spirals
Ontology: Depressive relapse maintained by reactivation of ruminative cognitive patterns triggered by low mood
Related condition topics
These editorial cross-references organize reading. A shared link does not mean both approaches are effective, recommended, or interchangeable for that condition.
2 shared · 4 CBT-I-only · 0 MBCT-only
Linked to both entries
Linked only in the CBT-I entry
What each assumes — and misses
CBT-I
Philosophical roots: Behavioral learning theory (Pavlov, Skinner); cognitive appraisal theory; Spielman's 3P model (predisposing, precipitating, perpetuating factors)
Blind spots: Sleep restriction can be challenging for people with bipolar disorder (may trigger mania); requires motivation and tolerance of short-term worsening; group or digital formats may not address comorbidities
Therapeutic voice: We're going to compress the time you spend in bed to build up your sleep drive. It will feel harder before it feels easier.
MBCT
Philosophical roots: Buddhist psychology (mindfulness, non-attachment to thoughts); Husserl (epoché: suspending natural attitude); Kabat-Zinn (secularized dharma); Teasdale (interacting cognitive subsystems)
Blind spots: Primarily relapse prevention: not first-line for acute depression; requires meditation capacity some clients lack
Therapeutic voice: Notice the thought arriving, not as truth, but as a mental event. Thoughts are not facts.
Choosing between them
CBT-I and MBCT both sit within the Cognitive-Behavioral tradition — they share a worldview about what suffering is and how change happens. Differences are more often about technique and emphasis than about underlying theory.
For deeper coverage: see the full CBT-I and MBCT pages, or use the interactive comparison tool to add more modalities to this comparison.